Kristina Lindemann

Associate professor Kristina Lindemann is a staff specialist and Head of Research at the Department of Gynecological Oncology at Oslo University Hospital. She also leads the National Advisory Unit of Gynecological Oncology.

She received her medical degree at the Ludwig-Maximilians University in Munich and completed her doctoral degree in the research group of Prof. Nadia Harbeck. She completed her OB/GYN training at the Akershus University Hospital in Oslo and defended her PhD on “Obesity and the risk of endometrial cancer” in 2010. The Global Clinical Scholars Research Training Program at Harvard Medical School added to her research training with focus on clinical trial conduction. Between 2015 and 2016 she joined the Crown Princess Mary Cancer Centre, Westmead, and the NHMRC Clinical Trials Centre in Sydney for a fellowship.

As Deputy Medical Director of NSGO (Nordic Society of Gynaecological Oncology), she is at the forefront of international clinical trials in gynae-oncology. She is Principal Investigator of multiple international phase II-III trials in gynae-oncology, and has recently initiated a multicenter international trial in end-of-life care in gynae-oncology patients. Her research focus is to improve patient care in gynaecological cancers, through advancing and translating knowledge in cancer biology, drug development and supportive care. Her translational research focus is in endometrial cancer research.

Kristina Lindemann has been awarded for outstanding research (Akershus University Hospital, 2011; Oncological Forum, 2011; ASGO 2016) and received an ASCO merit award in 2018. She is also highly engaged in the education of younger colleagues. She has co-authored the IGCS palliative care curriculum for palliative care and leads a pilot project to enhance evidence-based learning at the University of Oslo funded by the Center for Sustainable Health Education.